Lazarus 3D, Inc.
- Raised $6 million (2022)
- FDA-cleared or approved devices
- Research grants: $1.5 million
- Founded 2021
Life science companies
Explore 12,266 biotech, pharmaceutical, medical device, CRO and CDMO companies. Filter by type, location, clinical trials, funding, FDA registrations and research focus, then see the insights or the map. Free, and new companies are added every day.
Lumen Bioscience, Inc.
- Private funding (2025)
- 7 clinical trials, 2 active
- Research grants: $7 million
- Founded 2017
MBX Biosciences, Inc.
Nasdaq: MBX
- Raised $47 million (2022)
- 8 clinical trials, 3 active
- Founded 2019
Mimedx Group, Inc.
Nasdaq: MDXG
- Raised $4 million (2016)
- 35 clinical trials, 2 active
- Founded 2008
Sapere Bio, Inc.
- Raised $500,000 (2024)
- 5 clinical trials
- Research grants: $7.9 million
Knopp Biosciences LLC
- Raised $1 (2021)
- 13 clinical trials
- Research grants: $12 million
- Founded 2010
Bioventus Inc.
Nasdaq: BVS
- 15 clinical trials, 1 active
- FDA-cleared or approved devices
Arrevus, Inc.
- Raised $150,000 (2019)
- 5 clinical trials
- Research grants: $8.5 million
- Founded 2015
AVITA Medical, Inc.
Nasdaq: RCEL
- Raised $15 million (2019)
- 15 clinical trials
Bionano Genomics, Inc.
Nasdaq: BNGO
- Raised $20 million (2024)
- 1 clinical trial
- Founded 2007
Cabaletta Bio, Inc.
Nasdaq: CABA
- Raised $50 million (2019)
- 7 clinical trials, 5 active
- Founded 2017
CalciMedica, Inc.
Nasdaq: CALC
- Raised $9.1 million (2023)
- 7 clinical trials
- Founded 2015
Camp4 Therapeutics Corp
Nasdaq: CAMP
- Raised $100 million (2022)
- 1 clinical trial, 1 active
- Founded 2015
Concerto Biosciences, Inc.
- Raised $25 million (2022)
- 1 clinical trial
- Research grants: $599,814
- Founded 2020
Immuneering Corp
Nasdaq: IMRX
- Raised $25 million (2025)
- 3 clinical trials, 2 active
IN8BIO, Inc.
Nasdaq: INAB
- Raised $20 million (2025)
- 1 clinical trial, 1 active
- Founded 2018
Insight Molecular Diagnostics Inc.
Nasdaq: IMDX
- Raised $22 million (2025)
- 3 clinical trials, 2 active
IsoPlexis Corp
- Raised $1.3 million (2014)
- Research grants: $38 million
- Founded 2013
Lyell Immunopharma, Inc.
Nasdaq: LYEL
- Raised $493 million (2020)
- 7 clinical trials, 3 active
- Founded 2018
Pliant Therapeutics, Inc.
Nasdaq: PLRX
- Raised $100 million (2020)
- 7 clinical trials, 1 active
- Founded 2015
Shattuck Labs, Inc.
Nasdaq: STTK
- Raised $83 million (2020)
- 7 clinical trials, 2 active
- Founded 2016
Tectonic Therapeutic, Inc.
Nasdaq: TECX
- Raised $185 million (2025)
- 1 clinical trial, 1 active
- Founded 2015
TherOx, Inc.
- Raised $15 million (2018)
- 7 clinical trials, 1 active
- Research grants: $97,670
Cytokinetics Inc
Nasdaq: CYTK
- 44 clinical trials, 5 active
- Research grants: $499,800
Earlens Corp
- Raised $8 million (2025)
- 3 clinical trials
- FDA-cleared or approved devices
- Research grants: $2.1 million
Neuroptics Inc
- Raised $500,000 (2016)
- 1 clinical trial, 1 active
- 1 FDA-registered device site
- Research grants: $5.4 million
MedShape, Inc.
- Raised $700,000 (2014)
- 6 clinical trials
- FDA-cleared or approved devices
- Research grants: $2.7 million
Auxilium Biotechnologies Inc.
- Raised $3.9 million (2025)
- 1 clinical trial, 1 active
- Research grants: $6.7 million
- Founded 2019
Claria Medical, Inc.
- Raised $4.5 million (2021)
- FDA-cleared or approved devices
- Research grants: $7.8 million
- Founded 2017
Enspectra Health, Inc.
- Raised $7.3 million (2019)
- 2 clinical trials
- Research grants: $16 million
- Founded 2012
GreenMark Biomedical Inc.
- Raised $500,000 (2022)
- FDA-cleared or approved devices
- Research grants: $4.5 million
- Founded 2016
Metabolon, Inc
- Raised $7.5 million (2025)
- Research grants: $1.4 million
Travere Therapeutics, Inc.
Nasdaq: TVTX
- Raised $25 million (2013)
- 14 clinical trials, 6 active
Azevan Pharmaceuticals Inc
- Raised $2.2 million (2013)
- 9 clinical trials, 1 active
- Research grants: $23 million
Aardvark Therapeutics, Inc.
Nasdaq: AARD
- Raised $85 million (2024)
- 6 clinical trials
- Founded 2017
Biovie Inc.
Nasdaq: BIVI
- Raised $6 million (2022)
- 6 clinical trials
- Founded 2013
Climb Bio, Inc.
Nasdaq: CLYM
- Raised $110 million (2026)
- 6 clinical trials, 5 active
- Founded 2018
Compass Therapeutics, Inc.
Nasdaq: CMPX
- Raised $110 million (2018)
- 7 clinical trials, 4 active
- Founded 2014
Jade Biosciences, Inc.
Nasdaq: JBIO
- Raised $76 million (2020)
- 6 clinical trials, 4 active
- Founded 2018
Lite Strategy, Inc.
Nasdaq: LITS
- Raised $75 million (2018)
- 13 clinical trials
Oligomerix, Inc.
- Raised $75,000 (2024)
- 1 clinical trial, 1 active
- Research grants: $40 million
TherapeuticsMD, Inc.
Nasdaq: TXMD
- Raised $1.1 million (2023)
- 6 clinical trials
- Founded 2010
TuHURA Biosciences, Inc./NV
Nasdaq: HURA
- Raised $1.5 million (2025)
- 6 clinical trials, 2 active
- Founded 2009
Neutrolis Inc.
- Raised $3.5 million (2025)
- 2 clinical trials, 1 active
- Research grants: $922,488
- Founded 2017
Outset Medical, Inc.
Nasdaq: OM
- Raised $3.9 million (2025)
- FDA-cleared or approved devices
United Health Products, Inc.
OTC: UEEC
- Raised $56,725 (2016)
- 1 clinical trial
- 1 FDA-registered device site
Altimmune, Inc.
Nasdaq: ALT
- Raised $19 million (2009)
- 25 clinical trials, 2 active
- Founded 2005
Actuate Therapeutics, Inc.
Nasdaq: ACTU
- Raised $4.7 million (2025)
- 5 clinical trials, 2 active
- Founded 2015
Allay Therapeutics, Inc.
- Raised $45 million (2025)
- 2 clinical trials
- Research grants: $502,226
Anavex Life Sciences Corp.
Nasdaq: AVXL
- Raised $10 million (2014)
- 13 clinical trials, 1 active
Published company profiles only; counts update daily. Data licences